This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Talk:2-FMA: Difference between revisions
>Unity m Typo fix |
>Pharmreduction Grammatics |
||
| (One intermediate revision by the same user not shown) | |||
| Line 18: | Line 18: | ||
: Hope this was helpful. Please let me know if you have any other questions. [[User:Clarity|Clarity]] ([[User talk:Clarity|talk]]) 09:13, 14 August 2017 (CEST) | : Hope this was helpful. Please let me know if you have any other questions. [[User:Clarity|Clarity]] ([[User talk:Clarity|talk]]) 09:13, 14 August 2017 (CEST) | ||
== Citation needed rollback? == | |||
I was wondering why these 3 effects are special among the others and need a specific citation since none of the others need it. According to the previous point on the talk page, effects were able to be added based off of the drug's similarity to amphetamine, surely abnormal heartbeat, and increased heartrate and blood pressure are basic enough effects of stimulants that they don't have to be specifically cited? How would you even go about sourcing an index effect especially for research chemicals? There aren't trip reports attached to every any of the listed effects let alone all of them and even then it would just be anecdotal claims since it's not part of a study or something. [[User:Pharmreduction|Pharmreduction]] ([[User talk:Pharmreduction|talk]]) 20:57, 13 August 2017 (PST) | |||